J&J Unit Sets Funds Aside For Risperdal Settlement
Johnson & Johnson said in a filing with regulators Tuesday that one of its subsidiaries had reserved money to potentially settle a federal criminal investigation into the off-label promotion of the...To view the full article, register now.
Already a subscriber? Click here to view full article